Activities per year
Activities
- 1 - 50 out of 189 results
Search results
-
Bdelloid rotifers and P. polycephalum as model for space research
Hespeels, B. (Speaker)
2 Sept 2025 → 4 Sept 2025Activity: Talk or presentation types › Invited talk
-
Bdelloid and Kubik, toward new discoveries
Hespeels, B. (Speaker)
16 Apr 2025 → 17 Apr 2025Activity: Talk or presentation types › Invited talk
-
Risque thrombotique des oestroprogestatifs
Douxfils, J. (Speaker)
3 Apr 2025Activity: Talk or presentation types › Invited talk
-
Lower reporting of venous thromboembolisms events with natural estrogen-based COCs compared to ethinylestradiol containing pills: A disproportionality analysis of the Eudravigilance database.
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Towards safer and more responsible use of estrogen-based oral contraceptives
Douxfils, J. (Speaker)
22 Mar 2025Activity: Talk or presentation types › Invited talk
-
Does E4/DRSP have minimal impact on hemostasis and VTE risk? The evidence is growing
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Invited talk
-
Risque thrombotique des oestroprogestatifs : quoi de neuf ?
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
Risque thromboembolique veineux de l’add back thérapie
Douxfils, J. (Speaker)
13 Mar 2025Activity: Talk or presentation types › Invited talk
-
Gender Equity in Osteoporosis Pharmacological Treatment: Evidence from a Recent Meta-Analysis
Beaudart, C. (Speaker)
20 Feb 2025Activity: Talk or presentation types › Invited talk
-
Vers une utilisation plus sûre et responsable des contraceptifs oraux à base d'estrogène
Douxfils, J. (Speaker)
11 Feb 2025Activity: Talk or presentation types › Invited talk
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
17 Dec 2024Activity: Talk or presentation types › Invited talk
-
The normalized Activated Protein C sensitivity ratio (nAPCsr): the INR of the gynecologist for a safer prescription of estrogen-containing products
Douxfils, J. (Speaker)
11 Dec 2024Activity: Talk or presentation types › Invited talk
-
Exploring UHDR Irradiation Parameters and FLASH Effect Occurrence on C. elegans and Tumor Spheroids
Heuskin, A.-C. (Speaker)
6 Nov 2024 → 7 Nov 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
20 Jun 2024Activity: Talk or presentation types › Invited talk
-
Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Douxfils, J. (Speaker)
10 Jun 2024Activity: Talk or presentation types › Invited talk
-
Estetrol - an estrogen through life: Cardiovascular impact and the risk of VTE
Douxfils, J. (Speaker)
4 Jun 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
27 Jun 2024Activity: Talk or presentation types › Invited talk
-
Is there new data to support the screening of women for hereditary thrombophilia before prescribing pills?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Is there a physiological explanation to VTE risk observed in epidemiological studies?
Douxfils, J. (Speaker)
1 May 2024Activity: Talk or presentation types › Invited talk
-
Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using DOAC Dipstick in Various Indications
Harenberg, J. F. (Speaker), Ageno, W. (Speaker), Becattini, C. (Speaker), Douxfils, J. (Speaker), Falanga, A. (Speaker), Hetjens, S. (Speaker), Marchetti, M. (Speaker), Vassart, J. (Speaker), Violi, F. (Speaker), Weiss, C. (Speaker) & Weitz, J. I. (Speaker)
17 May 2024Activity: Talk or presentation types › Invited talk
-
DOACs and Reversal Agents
Douxfils, J. (Speaker)
10 Apr 2024Activity: Talk or presentation types › Invited talk
-
Thromboses associées aux contraceptifs hormonaux combinés: évaluation du risque et suivi thérapeutique par un nouveau test, le nAPCr
Douxfils, J. (Speaker)
18 Apr 2024Activity: Talk or presentation types › Invited talk
-
Cardiovascular safety: the point of view of the veins
Douxfils, J. (Speaker)
8 Mar 2024Activity: Talk or presentation types › Invited talk
-
Outcomes of a new systematic literature review and meta-nalaysis effects of anti-osteoporosis medications on BMD in men
Beaudart, C. (Speaker)
Mar 2024 → …Activity: Talk or presentation types › Invited talk
-
Innovative biomarkers in sepsis
Douxfils, J. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
16 Mar 2024Activity: Talk or presentation types › Invited talk
-
Risque de thrombose associés aux contraceptifs hormonaux combinés - pourquoi l’évaluation de la résistance à la protéine C activée, appelée nAPCsr, est-elle importante?
Douxfils, J. (Speaker)
22 Feb 2024Activity: Talk or presentation types › Invited talk
-
Sensibilisation des étudiants aux compétences métiers et aux soft skills à travers la rédaction d'un portfolio
Hontoir, F. (Speaker)
2 Feb 2024Activity: Talk or presentation types › Invited talk
-
Atelier 2 - Action et expression - Dispositif d'apprentissage intégré de la physiologie et de l'anatomie du système digestif en médecine vétérinaire
Hontoir, F. (Speaker)
2 Feb 2024Activity: Talk or presentation types › Invited talk
-
Hormones-induced Coagulopathies — Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker)
25 Jan 2024Activity: Talk or presentation types › Invited talk
-
Patient Reported Outcome in Sarcopenia
Beaudart, C. (Speaker)
2024 → …Activity: Talk or presentation types › Invited talk
-
Outcomes of a new systematic literature review and meta-nalaysis effects of anti-osteoporosis medications on BMD in men
Beaudart, C. (Speaker)
2024 → …Activity: Talk or presentation types › Invited talk
-
Patient Reported Outcome in Sarcopenia
Beaudart, C. (Speaker)
2024Activity: Talk or presentation types › Invited talk
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Douxfils, J. (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Douxfils, J. (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Building a dynamic social vulnerability index using Facebook data
Dujardin, S. (Invited speaker), Vibar, A. A. B. (Speaker), Paulus, R. (Speaker), Linard, C. (Speaker) & Kienberger, S. (Speaker)
10 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Douxfils, J. (Speaker)
14 Nov 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker) & Morimont, L. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
2nd NETSKINMODELS COST meeting
Poumay, Y. (Invited speaker)
13 Sept 2023 → 15 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Douxfils, J. (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
GRC meeting: Barrier Function of Mammalian Skin
Poumay, Y. (Invited speaker)
6 Aug 2023 → 11 Aug 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Douxfils, J. (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Round table “Habitability”: Rotifer In Space
Hespeels, B. (Speaker)
6 Jul 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Douxfils, J. (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Douxfils, J. (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Douxfils, J. (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Douxfils, J. (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Douxfils, J. (Invited speaker) & Morimont, L. (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk